Hepatitis C Therapy

Study finds IFN-alpha not as effective for African Americans as Caucasians

Published in Hepatitis Weekly, July 14th, 2003

In some patients resistance to treatment for hepatitis C can be detected as early as the first 3 days of treatment, according to a paper recently published in Hepatology.

This knowledge should help clinicians predict the effectiveness of individual treatments and consequently decide who should go through such a regimen.

Jennifer Layden-Almer, leading the clinical study at the Department of Medicine, University of Illinois, Chicago, and Ruy Ribeiro, of the Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, USA, and Oxford University, U.K., responsible for the mathematical modeling, show that in African Americans, a group...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2003-07-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry